Leona Cuttler

Summary

Affiliation: Case Western Reserve University
Country: USA

Publications

  1. ncbi Overcoming burdens in the regulation of clinical research in children. Proceedings of a consensus conference, in historical context
    Robert J Levine
    The University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
    Int J Pediatr Endocrinol 2011:19. 2011
  2. ncbi Growth hormone and health policy
    Leona Cuttler
    Division of Pediatric Endocrinology, Diabetes, and Metabolism and The Center for Child Health and Policy, Rainbow Babies and Children s Hospital, Room 737, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    J Clin Endocrinol Metab 95:3149-53. 2010
  3. ncbi Patient, physician, and consumer drivers: referrals for short stature and access to specialty drugs
    Leona Cuttler
    Department of Pediatrics, Rainbow Babies and Children s Hospital, University Hospitals Case Medical Center, Cleveland, Ohio, USA
    Med Care 47:858-65. 2009
  4. ncbi State Children's Health Insurance Program and Pediatrics: background, policy challenges, and role in child health care delivery
    Leona Cuttler
    The Rainbow Center for Child Health Policy, Rainbow Babies and Children's Hospital, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106, USA
    Arch Pediatr Adolesc Med 161:630-3. 2007
  5. ncbi A national study of physician recommendations to initiate and discontinue growth hormone for short stature
    J B Silvers
    Weatherhead School of Management, Department of Internal Medicine, MetroHealth Medical Center, School of Medicine, Rainbow Babies and Children s Hospital, Case Western Reserve University, 11100 Euclid Ave, Room 737, Cleveland, OH 44106, USA
    Pediatrics 126:468-76. 2010
  6. ncbi Physician decisions to discontinue long-term medications using a two-stage framework: the case of growth hormone therapy
    Leona Cuttler
    Department of Pediatrics, Case Western Reserve University, Cleveland, OH 44106, USA
    Med Care 43:1185-93. 2005
  7. ncbi Change in prevalence of chronic conditions between childhood and adolescence among extremely low-birth-weight children
    Maureen Hack
    Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio, USA
    JAMA 306:394-401. 2011
  8. ncbi Idiopathic short stature: decision making in growth hormone use
    Nidhi Maheshwari
    Division of Pediatric Endocrinology and Diabetes, The Center for Child Health and Policy, Department of Pediatrics, Rainbow Babies and Children s Hospital, Case Western Reserve University, 11100 Euclid Avenue, Room 737, Cleveland, OH 44106, USA
    Indian J Pediatr 79:238-43. 2012
  9. ncbi Growth hormone therapy and quality of life in adults and children
    Deborah J Radcliffe
    Department of Pediatrics, Rainbow Babies and Childrens Hospital, Case Western Reserve University, Cleveland, Ohio 44106, USA
    Pharmacoeconomics 22:499-524. 2004
  10. ncbi Treatment of childhood obesity
    Naveen Uli
    Division of Endocrinology and Diabetes, Rainbow Babies and Childrens Hospital, Cleveland, Ohio 44106, USA
    Curr Opin Endocrinol Diabetes Obes 15:37-47. 2008

Collaborators

Detail Information

Publications18

  1. ncbi Overcoming burdens in the regulation of clinical research in children. Proceedings of a consensus conference, in historical context
    Robert J Levine
    The University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
    Int J Pediatr Endocrinol 2011:19. 2011
    ..abstract:..
  2. ncbi Growth hormone and health policy
    Leona Cuttler
    Division of Pediatric Endocrinology, Diabetes, and Metabolism and The Center for Child Health and Policy, Rainbow Babies and Children s Hospital, Room 737, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    J Clin Endocrinol Metab 95:3149-53. 2010
    ..In this paper, we highlight key policy issues exemplified by GH, focusing on pharmaceutical innovation, insurance coverage and pricing, and physician decisions, and we discuss their implications for endocrinology and GH use...
  3. ncbi Patient, physician, and consumer drivers: referrals for short stature and access to specialty drugs
    Leona Cuttler
    Department of Pediatrics, Rainbow Babies and Children s Hospital, University Hospitals Case Medical Center, Cleveland, Ohio, USA
    Med Care 47:858-65. 2009
    ..Recent expanded approval of growth hormone (GH) makes more than 585,000 US children eligible for such treatment, potentially costing over $11 billion/y...
  4. ncbi State Children's Health Insurance Program and Pediatrics: background, policy challenges, and role in child health care delivery
    Leona Cuttler
    The Rainbow Center for Child Health Policy, Rainbow Babies and Children's Hospital, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106, USA
    Arch Pediatr Adolesc Med 161:630-3. 2007
  5. ncbi A national study of physician recommendations to initiate and discontinue growth hormone for short stature
    J B Silvers
    Weatherhead School of Management, Department of Internal Medicine, MetroHealth Medical Center, School of Medicine, Rainbow Babies and Children s Hospital, Case Western Reserve University, 11100 Euclid Ave, Room 737, Cleveland, OH 44106, USA
    Pediatrics 126:468-76. 2010
    ..We studied how physicians decided to begin GH in idiopathic short stature and how, after an initial course of treatment, they decided to continue, intensify (increase the dose), or terminate treatment...
  6. ncbi Physician decisions to discontinue long-term medications using a two-stage framework: the case of growth hormone therapy
    Leona Cuttler
    Department of Pediatrics, Case Western Reserve University, Cleveland, OH 44106, USA
    Med Care 43:1185-93. 2005
    ..The decision to stop growth hormone (GH) therapy is an important example because of high cost (approximately $26,000/y for a 48-kg child), complexity of treatment options, and expansion of patient populations...
  7. ncbi Change in prevalence of chronic conditions between childhood and adolescence among extremely low-birth-weight children
    Maureen Hack
    Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio, USA
    JAMA 306:394-401. 2011
    ..Extremely low-birth-weight (ELBW) children have high rates of chronic conditions during childhood. Information on their trajectory of health during adolescence is needed for health care planning...
  8. ncbi Idiopathic short stature: decision making in growth hormone use
    Nidhi Maheshwari
    Division of Pediatric Endocrinology and Diabetes, The Center for Child Health and Policy, Department of Pediatrics, Rainbow Babies and Children s Hospital, Case Western Reserve University, 11100 Euclid Avenue, Room 737, Cleveland, OH 44106, USA
    Indian J Pediatr 79:238-43. 2012
    ..This article focuses on current ambiguities and controversies regarding GH therapy in ISS, discusses the decision-makers involved in GH therapy, and explores the factors influencing their decisions...
  9. ncbi Growth hormone therapy and quality of life in adults and children
    Deborah J Radcliffe
    Department of Pediatrics, Rainbow Babies and Childrens Hospital, Case Western Reserve University, Cleveland, Ohio 44106, USA
    Pharmacoeconomics 22:499-524. 2004
    ..These analyses are central to the development of a framework for research, decision making, and policy for GH treatment...
  10. ncbi Treatment of childhood obesity
    Naveen Uli
    Division of Endocrinology and Diabetes, Rainbow Babies and Childrens Hospital, Cleveland, Ohio 44106, USA
    Curr Opin Endocrinol Diabetes Obes 15:37-47. 2008
    ..To provide an overview of treatments for childhood obesity, highlighting recent advances and recommendations...
  11. ncbi Idiopathic short stature
    Rose A Gubitosi-Klug
    Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA
    Endocrinol Metab Clin North Am 34:565-80, viii. 2005
    ....
  12. ncbi Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents
    Robert C Strunk
    Department of Pediatrics, Washington University School of Medicine, St Louis Children s Hospital, St Louis, MO 63110, USA
    J Pediatr 154:682-7. 2009
    ..To determine whether long-term, continuous use of inhaled anti-inflammatory medications affects asthma outcomes in children with mild to moderate asthma after use is discontinued...
  13. ncbi Parent involvement is associated with early success in obesity treatment
    Leslie J Heinberg
    Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
    Clin Pediatr (Phila) 49:457-65. 2010
    ..The study examined the influence of parent involvement and family factors on body mass index (BMI) change in a pediatric obesity treatment program...
  14. ncbi Growth of very low birth weight infants to age 20 years
    Maureen Hack
    Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio, USA
    Pediatrics 112:e30-8. 2003
    ..As part of a longitudinal study of VLBW infants, we sought to examine gender-specific changes in growth from birth to 20 years old and to identify the correlates of growth attainment at 20 years old...
  15. ncbi The overweight adolescent: clinical and ethical issues in intensive treatments for pediatric obesity
    Leona Cuttler
    Division of Pediatric Endocrinology and Metabolism, Rainbow Babies and Children's Hospital, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    J Pediatr 146:559-64. 2005
  16. ncbi Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study
    H William Kelly
    Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131 0001, USA
    Pediatrics 122:e53-61. 2008
    ..Thus, we assessed the effects of multiple short courses of oral corticosteroids and long-term inhaled corticosteroids on bone mineral accretion over a period of years...
  17. ncbi Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis
    Beth S Finkelstein
    Department of Pediatrics, Rainbow Babies and Children's Hospital, Room 737, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106, USA
    Arch Pediatr Adolesc Med 156:230-40. 2002
    ..Use of GH for idiopathic short stature in clinical practice will depend on its efficacy in promoting growth and the value of this effect to families, physicians, and third-party payers...
  18. ncbi Growth hormone treatment for idiopathic short stature: implications for practice and policy
    Leona Cuttler
    Arch Pediatr Adolesc Med 158:108-10. 2004